This follows encouraging early results in both France and China. French pharmaceutical company Sanofi said it was ready to offer the French government millions of doses of hydroxychloroquine, sold under its brand name Plaquenil. Olivier Bogillot, president of Sanofi France told France 24 on March 22: "We will start probably tomorrow to give the drug to the patients. Once we have the results, we will be in a position to produce and deliver a huge number of doses. "In the future, we have to change the rules: when you produce in Europe, you have to be rewarded," he told FRANCE 24’s Annette Young.

Source: The Standard April 10, 2020 08:26 UTC